![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CLEW Medical Earns FDA Clearance for ICU Patient-Assessment Tool
CLEW Medical Earns FDA Clearance for ICU Patient-Assessment Tool
February 5, 2021
CLEW Medical has received 510(k) clearance for CLEWICU, an artificial intelligence-based device that is used to predict hemodynamic instability — abnormal or unstable blood pressure — in adult intensive care patients.
The technology continuously monitors and categorizes patient risk levels using electronic health records and medical device data, offering clinicians insights into a patient’s risk of future hemodynamic instability.
The system gives notifications of clinical deterioration up to eight hours in advance, enabling early intervention. It also identifies low-risk patients unlikely to have blood pressure complications.
Upcoming Events
-
21Oct